Acadia Pharmaceuticals Inc (ACAD) Q2 2025 Earnings Call Transcript
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) Q2 2025 Earnings Call dated Aug. 06, 2025 Corporate Participants: Al Kildani — Senior Vice President of Investor Relations &…
Acadia Pharmaceuticals Inc (ACAD) Q3 2025 Earnings Call Transcript
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) Q3 2025 Earnings Call dated Nov. 05, 2025 Corporate Participants: Al Kildani — Senior Vice President, Investor Relations & Corporate…
Market News
ACADIA Pharmaceuticals (ACAD): Q4 2019 Earnings Snapshot
— ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) reported Q4 2019 loss of $0.34 per share, vs. $0.36 expected. — Revenue grew 65% to $98.3 million vs.…
Market News
ACADIA Pharmaceuticals (ACAD): Q3 2019 Earnings Snapshot
— ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) reported Q3 2019 loss of $0.29 per share, vs. $0.40 expected. — Revenues grew 62% to $94.6 million, vs.…